RespireRx Pharmaceuticals Inc (fka RSPI)

[Market_Fest4]

Perhaps, what's really needed is an overhaul of the FDA process? The barriers to drug development are high cost and liability, which is typically shouldered by the U.S. population in the form of high drug prices before going generic. If the FDA could be encouraged to streamline the process, perhaps Cortex could get something going?
MF4